-
1دورية أكاديمية
المؤلفون: Dandan HU, Peimiao ZHANG
المصدر: Pifu-xingbing zhenliaoxue zazhi, Vol 30, Iss 3, Pp 246-252 (2023)
مصطلحات موضوعية: secukinumab, adalimumab, conventional therapy, moderate to severe plaque psoriasis, Dermatology, RL1-803
وصف الملف: electronic resource
العلاقة: http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.03.011Test; https://doaj.org/toc/1674-8468Test
-
2دورية أكاديمية
المؤلفون: F. Marsili, M. Travaglini, G. Stinco, R. Manzoni, R. Tiberio, F. Prignano, A. Mazzotta, S. P. Cannavò, A. Cuccia, M. Germino, M. R. Bongiorno, S. Persechino, T. Florio, M. Pettinato, M. Tabanelli, R. Sarkar, E. Aloisi, M. Bartezaghi, R. Orsenigo
المصدر: Journal of Dermatological Treatment, Vol 33, Iss 1, Pp 401-407 (2022)
مصطلحات موضوعية: moderate to severe plaque psoriasis, systemic therapy, cyclosporine a, pasi, Dermatology, RL1-803
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Bei-bei SU, Quan GAN, Cai-bin GAN
المصدر: Pifu-xingbing zhenliaoxue zazhi, Vol 27, Iss 5, Pp 301-306 (2020)
مصطلحات موضوعية: moderate to severe plaque psoriasis, methotrexate, cytokines, therapeutic mechanism, Dermatology, RL1-803
وصف الملف: electronic resource
العلاقة: http://pfxbzlx.gdvdc.com/CN/abstract/abstract1861.shtmlTest; https://doaj.org/toc/1674-8468Test
-
4مؤتمر
المؤلفون: NIKKELS, Arjen, Hamza, Ashraf, Pearl, Kwong, Ortmann, Christine-Elke, Papanastasiou, Philemon, Forrer, Pascal, Keefe, Deborah, Sticherling, Michael
مصطلحات موضوعية: Safety analysis, Secukinumab, Paediatric patients, Moderate to severe plaque psoriasis, Studies, interleukin-17A, Human health sciences :: Dermatology, Sciences de la santé humaine :: Dermatologie
جغرافية الموضوع: international
العلاقة: European Academy of Dermatology and Venereology (EADV) (du 6 au 7 mai 2021)
الوصول الحر: https://orbi.uliege.be/handle/2268/264003Test
-
5دورية أكاديمية
المؤلفون: Berry, Angel L
المصدر: PCOM Physician Assistant Studies Student Scholarship
مصطلحات موضوعية: moderate to severe plaque psoriasis, Risankizumab, Medicine and Health Sciences
وصف الملف: application/pdf
العلاقة: https://digitalcommons.pcom.edu/pa_systematic_reviews/613Test; https://digitalcommons.pcom.edu/context/pa_systematic_reviews/article/1582/viewcontent/Publication_Version_for_Digital_Commons_ab8542_attempt_2021_05_26_15_08_22_BerryA.pdfTest
-
6
المؤلفون: R Manzoni, A. Cuccia, M Germino, R Orsenigo, R Sarkar, S.P. Cannavò, Francesca Prignano, Michela Tabanelli, Giuseppe Stinco, F Marsili, Rossana Tiberio, Marta Bartezaghi, Severino Persechino, M Pettinato, E Aloisi, T Florio, Maria Rita Bongiorno, Annamaria Mazzotta, M Travaglini
المساهمون: Marsili, F, Travaglini, M, Stinco, G, Manzoni, R, Tiberio, R, Prignano, F, Mazzotta, A, Cannavò, S P, Cuccia, A, Germino, M, Bongiorno, M R, Persechino, S, Florio, T, Pettinato, M, Tabanelli, M, Sarkar, R, Aloisi, E, Bartezaghi, M, Orsenigo, R
مصطلحات موضوعية: Moderate to severe, Male, medicine.medical_specialty, systemic therapy, macromolecular substances, Dermatology, Systemic therapy, Severity of Illness Index, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Psoriasis, Medicine, Humans, In patient, PASI, cyclosporine A, moderate to severe plaque psoriasis, 030203 arthritis & rheumatology, Plaque psoriasis, business.industry, Middle Aged, medicine.disease, moderate to severe plaque psoriasi, Cross-Sectional Studies, Treatment Outcome, Cyclosporine, Quality of Life, Female, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2079662afa537d66a961732249f3731bTest
http://hdl.handle.net/11570/3167630Test -
7تقرير
المصدر: A Multicenter, Randomized, Parallel-Group, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06425549Test
-
8تقرير
المصدر: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06109818Test
-
9تقرير
المصدر: A Phase Ⅰb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of TLL-018 in Subjects With Moderate to Severe Plaque Psoriasis
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05342428Test
-
10تقريرClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis
المصدر: An Open-label, Dose-escalation, Phase 1 Trial to Investigate the Safety, Tolerability, and Efficacy After Single- and Multiple-dose Administration of CT303 in Patients With Moderate to Severe Plaque Psoriasis
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05258331Test